(Q44006856)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

28 November 2017

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Statin enhances cytokine-mediated induction of nitric oxide synthesis in vascular smooth muscle cells (English)

1 reference

28 November 2017

Yoshiyuki Hattori

1

1 reference

PubMed ID

12031711

28 November 2017

Nobuo Nakanishi

series ordinal

2

1 reference

PubMed ID

12031711

28 November 2017

Kikuo Kasai

series ordinal

3

1 reference

28 November 2017

1 June 2002

1 reference

28 November 2017

Cardiovascular Research

1 reference

28 November 2017

54

1 reference

28 November 2017

3

1 reference

28 November 2017

649-658

1 reference

Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells

28 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900266-3

Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900266-3

Increased activity of guanylate cyclase in the atherosclerotic rabbit aorta: role of non-endothelial nitric oxide synthases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900266-3

Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900266-3

Inducible nitric oxide synthase and vascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900266-3

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900266-3

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900266-3

Regulation of the mevalonate pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900266-3

Protein lipidation in cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900266-3

Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900266-3

Inhibition of protein geranylgeranylation causes a superinduction of nitric-oxide synthase-2 by interleukin-1beta in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900266-3

Inhibition of small G proteins of the rho family by statins or clostridium difficile toxin B enhances cytokine-mediated induction of NO synthase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900266-3

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900266-3

Troglitazone upregulates nitric oxide synthesis in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900266-3

Oxygen reduction by nitric-oxide synthases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900266-3

Atherosclerosis and the two faces of endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900266-3

Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900266-3

Direct measurement of nitric oxide generation from nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900266-3

Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900266-3

The L-arginine-nitric oxide pathway: role in atherosclerosis and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900266-3

Biopharmaceutical profile of cerivastatin: a novel HMG-CoA reductase inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900266-3

Pharmacokinetics of fluvastatin after single and multiple doses in normal volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900266-3

Vastatins Inhibit Tissue Factor in Cultured Human Macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900266-3

Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900266-3

Overproduction of nitric oxide in cytokine-mediated and septic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900266-3

Distribution and prevalence of inducible nitric oxide synthase in atherosclerotic vessels of long-term cholesterol-fed rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900266-3

L-arginine prevents xanthoma development and inhibits atherosclerosis in LDL receptor knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900266-3

Cerivastatin suppresses lipopolysaccharide-induced ICAM-1 expression through inhibition of Rho GTPase in BAEC

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900266-3

3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors attenuate vascular smooth muscle proliferation by preventing rho GTPase-induced down-regulation of p27(Kip1)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900266-3

Nitric oxide as a secretory product of mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900266-3

The smooth muscle cell in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900266-3

GTP cyclohydrolase I mRNA is induced by LPS in vascular smooth muscle: characterization, sequence and relationship to nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900266-3

Analysis of reduced forms of biopterin in biological tissues and fluids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900266-3

Fluvastatin upregulates inducible nitric oxide synthase expression in cytokine-stimulated vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900266-3

Tetrahydrobiopterin and endothelial nitric oxide synthase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900266-3

Superoxide generation from endothelial nitric-oxide synthase. A Ca2+/calmodulin-dependent and tetrahydrobiopterin regulatory process

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900266-3

Tetrahydrobiopterin-dependent inhibition of superoxide generation from neuronal nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-6363%2802%2900266-3

10.1016/S0008-6363(02)00266-3

7 January 2021

Identifiers

DOI

1 reference

28 November 2017

1 reference

PubMed ID

12031711